Endurant Capital Management LP
- SEC CIK
- 0001633055
- Latest filing
- May 7, 2024
SPRY holding history
ARS Pharmaceuticals, Inc. in every 13F filed by Endurant Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SPRY overviewAll 13F holders of SPRYFull Q1 2024 holdings
- Shares (Q1 2022)
- 0
- Sold out in Q1 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 2
- Since Q2 2021